Lorazepam Stimulates IL6 Production and Is Associated with Poor Survival Outcomes in Pancreatic Cancer

CONCLUSIONS: We demonstrate that LOR stimulates fibrosis and inflammatory signaling, promotes desmoplasia and ischemic necrosis, and is associated with decreased pancreatic cancer patient survival.PMID:37587561 | DOI:10.1158/1078-0432.CCR-23-0547
Source: Clinical Cancer Research - Category: Cancer & Oncology Authors: Source Type: research